A Gender Transformative Implementation Strategy With Providers to Improve HIV Outcomes in Uganda
2 other identifiers
interventional
382
1 country
2
Brief Summary
Gender norms embedded in the health-system and broader community shape patient-provider relationships in ways that may undermine the provision of antiretroviral treatment (ART) counseling for men and women in Uganda. This study seeks to develop and evaluate the acceptability, feasibility, and preliminary efficacy of an innovative gender transformative implementation strategy to improve HIV provider capacity for equitable HIV care and ART adherence counseling.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable hiv
Started Dec 2021
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 15, 2021
CompletedStudy Start
First participant enrolled
December 31, 2021
CompletedFirst Posted
Study publicly available on registry
January 5, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2024
CompletedResults Posted
Study results publicly available
April 25, 2025
CompletedApril 25, 2025
April 1, 2025
2.1 years
November 15, 2021
January 27, 2025
April 8, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Change in Proportion of Missed Antiretroviral (ARV) Doses From Baseline Among Clients
AACTG Adherence Instruments, self-reported questionnaire on medication adherence from the Adult AIDS Clinical Trials Group (AACTG); operationalized as a proportion of total missed doses (missed doses/total doses) (continuous measure, range =0.0-1.0)
Baseline, 6-months, and 12-months
Change in Clinic Visit Adherence From Baseline Among Patients (Retention in Care)
Proportion of kept visits/scheduled visits (kept + missed visits) (continuous measure, range =0.0-1.0)
Baseline, 6-months, and 12-months
Change in Competence for Gender-sensitive Care From Baseline Among Providers
Adapted from the Nijmegen Gender Awareness in Medicine Scale (N-GAMS); collected from provider cohort; 9 items, total possible score using mean scoring: 1-5 (high score = better outcome)
Baseline, 6-months, and 12-months
Secondary Outcomes (10)
Change in Self-efficacy for Client-centered Communication From Baseline Among Providers
Baseline, 6-months, and 12-months
Change in Empathy Towards Clients From Baseline Among Providers
Baseline, 6-months, and 12-months
Change in the Use of Emotional Regulation and Stress Reduction Techniques From Baseline Among Providers
Baseline, 6-months, and 12-months
Change in Perceived Quality of Communication From HIV Providers From Baseline Among Clients
Baseline, 6-months, and 12-months
Change in Perceived Level of Participatory Decision-making Related to HIV Care From Baseline Among Clients
Baseline, 6-months, and 12-months
- +5 more secondary outcomes
Study Arms (4)
Intervention Providers
EXPERIMENTALHIV care providers and staff in the intervention arm will receive up to 4 sessions of training. Trained intervention facilitator experienced in health professional trainings will lead the training. The intervention content delivered is aimed to increase HIV providers' knowledge, motivation, skills, and empathy to: 1) equitably deliver ART program guidelines (i.e., quality of care) and 2) provide gender sensitive counseling to address ART patients' gendered barriers to HIV care engagement, increasing patient satisfaction, retention, and ART adherence, and reducing gender disparities in HIV outcomes.
Intervention Clients
EXPERIMENTALIn the intervention arm clinics, we will enroll a cohort of people living with HIV receiving HIV treatment at the clinics. While they do not receive a direct intervention, we measure change in their outcomes to assess if the provider training intervention has effects on client outcomes.
Control Providers
NO INTERVENTIONThe control arm will receive no training. This cohort is of HIV care providers and staff at clinics receiving no intervention.
Control Clients
NO INTERVENTIONThe control arm will receive no training. This cohort is of people living with HIV receiving HIV treatment at the control clinics, receiving no intervention.
Interventions
This training program integrates evidence-based strategies to reduce provider bias, adapted to address gender bias in the context of HIV care in Uganda. The content aims to increase providers' knowledge, motivation, skills, and empathy to equitably deliver Ugandan Ministry of Health ART program guidelines to male and female patients (e.g., increasing awareness of HIV gender disparities, increasing empathy/skills to counsel men and women's gendered barriers to care, promoting shared decision-making). The intervention is delivered in a series of group training sessions with HIV providers.
Eligibility Criteria
You may qualify if:
- HIV care provider at the selected clinics, including HIV medical and clinical officers, nurses, midwives, linkage facilitators, counselors.
- years of age or older
- Fluent in English or Luganda
- Patient Cohort:
- HIV-infected
- Enrolled in care at the clinic of recruitment
- pre-ART (newly diagnosed) or newly initiated on ART (within 3 months-1 year) or struggling with treatment adherence, defined in two ways: (1) most recent viral load results unsuppressed as assessed through clinic records; (2) or self-reported non-adherence as by the Adult AIDS Clinical Trials Group (AACTG) scale 4-day adherence recall questions. This scale has demonstrated good construct validity in Uganda and strong correlations with viral load;
- years of age or an emancipated minor
- Fluent in Luganda or English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The University of Texas at San Antoniolead
- Makerere Universitycollaborator
- National Institute of Mental Health (NIMH)collaborator
Study Sites (2)
Luwero Health HCIV
Luwero, Uganda
Namayumba Health HCIV
Namayumba, Uganda
Related Publications (2)
Sileo KM, Wanyenze RK, Anecho A, Luttinen RL, Weston K, Mukasa B, Mukama SC, Vermund SH, Dworkin SL, Dovidio JF, Taylor BS, Kershaw TS. Acceptability, feasibility, and factors affecting implementation of a gender-sensitivity training for HIV providers and staff in Uganda: a mixed methods, quasi-experimental controlled pilot trial. BMC Public Health. 2025 May 24;25(1):1925. doi: 10.1186/s12889-025-23008-4.
PMID: 40413446DERIVEDSileo KM, Wanyenze RK, Anecho A, Luttinen R, Semei C, Mukasa B, Musoke W, Vermund SH, Dworkin SL, Dovidio JF, Taylor BS, Kershaw TS. Protocol for the pilot quasi-experimental controlled trial of a gender-responsive implementation strategy with providers to improve HIV outcomes in Uganda. Pilot Feasibility Stud. 2022 Dec 23;8(1):264. doi: 10.1186/s40814-022-01202-0.
PMID: 36564795DERIVED
Limitations and Caveats
This study is a pilot trial. Therefore, the results reported are exploratory because they are underpowered. A full-scale efficacy trial is needed to replicate these results.
Results Point of Contact
- Title
- Katelyn Sileo
- Organization
- Boston College
Study Officials
- PRINCIPAL INVESTIGATOR
Katelyn M Sileo, PhD, MPH
University of Texas at San Antonio
- PRINCIPAL INVESTIGATOR
Rhoda K. Wanyenze, MBChB, MPH, PhD
Makerere School of Pubic Health
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 15, 2021
First Posted
January 5, 2022
Study Start
December 31, 2021
Primary Completion
January 31, 2024
Study Completion
January 31, 2024
Last Updated
April 25, 2025
Results First Posted
April 25, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- 3 years after study completion for researchers and students within the collaborating institutions and 5 years after study completion for those outside of the collaborating institutions upon request
- Access Criteria
- Upon request from the PI
Quantitative data collected in this trial (baseline, follow-up assessments) will be made available, under the following provisions: (1)The data will be fully de-identified; (2) Access to the data will be made available first to researchers and their students at the two collaborating institutions (within 3 years of study completion): The University of Texas at San Antonio and the Makerere University School of Public Health (MakSPH); 3) 5 years after study completion, data will be made available to those requesting access outside of the collaborating institutions. Qualitative data collected as part of this trial will not be made available, as it is difficult to fully de-identify and to interpret without knowledge of the context.